CYTOREASON
LIVE

Serial Number

88701153

Owner

Cytoreason Ltd.

Attorney

ROBYN S. LEDERMAN

Filing Date

Nov 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CYTOREASON Trademark

Serial Number: 88701153 • Registration: 6399432

CYTOREASON is a trademark filed by Cytoreason Ltd. on November 21, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cytoreason Ltd.

Azrieli Circular Tower, 16th Floor
Tel Aviv-Yafo 6701101 , IL

Entity Type: 99

Trademark Details

Filing Date

November 21, 2019

Registration Date

June 29, 2021

Published for Opposition

April 13, 2021

Goods & Services

Downloadable computer software for the purpose of analyzing and researching medical, scientific and clinical data in the field of medical diagnostics, drug research, drug development, drug delivery, medical treatment, clinical research, and pharmaceutical research; downloadable computer software based on artificial intelligence for the purpose of analyzing and researching medical, scientific and clinical data in the field of medical diagnostics, drug research, drug development, drug delivery, medical treatment, clinical research, and pharmaceutical research; downloadable computer software based on machine learning for the purpose of analyzing and researching medical, scientific and clinical data in the field of medical diagnostics, drug research, drug development, drug delivery, medical treatment, clinical research, and pharmaceutical research; downloadable computer software for the analysis and characterization of scientific, medical, and clinical data

Scientific and technological service, namely, medical, clinical, and biological research, analysis, and testing in the fields of medical diagnostics, drug research, drug development, drug delivery, medical treatment, clinical research, and pharmaceutical research; analysis and research services in the field of medical diagnostics, drug research, drug development, drug delivery, medical treatment, clinical research, and pharmaceutical research; research services for the analysis and characterization of medical, scientific, and clinical data

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Oct 29, 2024 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 25, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 13, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Feb 27, 2024 ES7R
REGISTERED-PRINCIPAL REGISTER
Jun 29, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
ASSIGNED TO LIE
Feb 16, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 12, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 29, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 29, 2020 GNSL
SUSPENSION LETTER WRITTEN
Aug 29, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 26, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 27, 2019 NWOS
NEW APPLICATION ENTERED
Nov 25, 2019 NWAP